Sector consensus Abbott Laboratories Buenos Aires S.E.
Stocks
ABT
ARDEUT110608
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Buenos Aires S.E.
2026-10-06
|
5-day change | 1st Jan Change | ||
| 39,500.00 ARS | -1.89% |
|
-3.04% | -17.33% |
| 08:14am | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 10-05 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 120.72 | +22.98% | 26 | |||||||
| 104.44 | +19.92% | 25 | |||||||
| 366.15 | +31.62% | 26 | |||||||
| 227.3 | +54.94% | 23 | |||||||
| 369.25 | +16.71% | 12 | |||||||
| 30,200 | +19.37% | 15 | |||||||
| 194.08 | +7.64% | 13 | |||||||
| 701.33 | +36.07% | 12 | |||||||
| 96.23 | +15.4% | 26 | |||||||
| 44.5 | +25.18% | 26 | |||||||
| 91.12 | +43.69% | 17 | |||||||
| 411 | +10.29% | 16 | |||||||
| 199.84 | +17.08% | 25 | |||||||
| 237.29 | +9.96% | 14 | |||||||
| 3,121.54 | +33.77% | 13 | |||||||
| 263.12 | +26.11% | 8 | |||||||
| 241.74 | -4.3% | 19 | |||||||
| 113.05 | +22.19% | 19 | |||||||
| 107.23 | +19.57% | 22 | |||||||
| Average | 1,958.42 | +22.54% | 19 | ||||||
| Weighted average by Cap. | 2,019.21 | +24.74% | 21 |
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Sector Abbott Laboratories
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















